Latest news from the EMCDDA

European Drug Report 2022

14.06.2022 - What do the latest data tell us about trends in drug use and the market? What hazardous new drugs are emerging? What substances are posing the greatest health threats? Find out more in the EMCDDA European Drug Report 2022, the latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions.

spacer3.jpg

Recreational use of nitrous oxide

11.2022 - Recreational use of nitrous oxide is a growing concern for Europe according to a new EMCDDA report.

EU measures to control 2 new cathinones

03.2022 - The European Commission has adopted measures to control 3-MMC and 3-CMC, after the risk assessments carried out by the extended Scientific Committee of the EMCDDA.

 

 

 

 

 

 

 

 

 

Quick access to the EMCDDA main publications archives

 Databases


OFDT_LOGO-COURT-BLANC_FOND-TRANSP_site_EN.png

The OFDT provides an online bibliographic database on addiction.

 
Books3.jpg

The EMCDDA provides a database on their publications of interest.

 

 

 

 

 

 

 

 

Drugs in Europe


2021 EMCDDA European Drug Report

COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug production and trafficking trends?

These and other questions are explored in the 2021 European Drug Report, our annual overview of the drug situation in Europe.

  Statistical Bulletin 2021

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.